Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.

De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, Tenet V, Njoroge JW, Sakr SR, Meijer CM, Snijders PJ, Rana FS, Franceschi S.

Br J Cancer. 2012 Oct 23;107(9):1624-30. doi: 10.1038/bjc.2012.441. Epub 2012 Oct 2.

2.

Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.

De Vuyst H, Mugo NR, Franceschi S, McKenzie K, Tenet V, Njoroge J, Rana FS, Sakr SR, Snijders PJ, Chung MH.

PLoS One. 2014 Oct 24;9(10):e111037. doi: 10.1371/journal.pone.0111037. eCollection 2014.

3.

Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.

Teixeira NC, Araújo AC, Correa CM, Lodi CT, Lima MI, Carvalho Nde O, Castillo DM, Melo VH.

Braz J Infect Dis. 2012 Mar-Apr;16(2):164-9.

4.

Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.

Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S.

BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25.

5.

Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.

Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Groupa.

Int J Gynecol Cancer. 2013 Mar;23(3):500-6. doi: 10.1097/IGC.0b013e318280f26e.

PMID:
23392401
6.

High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.

Rijkaart DC, Heideman DA, Coupe VM, Brink AA, Verheijen RH, Skomedal H, Karlsen F, Morland E, Snijders PJ, Meijer CJ.

J Clin Microbiol. 2012 Jul;50(7):2390-6. doi: 10.1128/JCM.06587-11. Epub 2012 May 2.

7.

Multiple human papillomavirus infections and HIV seropositivity as risk factors for abnormal cervical cytology among female sex workers in Nairobi.

Patel SJ, Mugo NR, Cohen CR, Ting J, Nguti R, Kwatampora J, Waweru W, Patnaik P, Donders GG, Kimani J, Kenney DL, Kiviat NB, Smith JS.

Int J STD AIDS. 2013 Mar;24(3):221-5. doi: 10.1177/0956462412472446. Epub 2013 May 6.

PMID:
23535357
8.

Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses.

Laukkanen P, Läärä E, Koskela P, Pukkala E, Virkkunen H, Lehtinen M.

Future Oncol. 2010 May;6(5):709-16. doi: 10.2217/fon.10.38.

PMID:
20465386
9.

Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India.

Peedicayil A, Thiyagarajan K, Gnanamony M, Pulimood SA, Jeyaseelan V, Kannangai R, Lionel J, Abraham OC, Abraham P.

J Low Genit Tract Dis. 2009 Jul;13(3):159-64. doi: 10.1097/LGT.0b013e31818fb40d.

PMID:
19550213
10.

Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru.

Almonte M, Ferreccio C, Gonzales M, Delgado JM, Buckley CH, Luciani S, Robles SC, Winkler JL, Tsu VD, Jeronimo J, Cuzick J, Sasieni P.

Int J Gynecol Cancer. 2011 Dec;21(9):1654-63. doi: 10.1097/IGC.0b013e3182288104.

PMID:
21892094
11.

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

Kjær SK, Frederiksen K, Munk C, Iftner T.

J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88. doi: 10.1093/jnci/djq356. Epub 2010 Sep 14.

12.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598
13.

Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.

Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.

Cancer Epidemiol. 2012 Oct;36(5):e284-7. doi: 10.1016/j.canep.2012.04.005. Epub 2012 May 17.

PMID:
22608058
14.

The ATHENA human papillomavirus study: design, methods, and baseline results.

Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL.

Am J Obstet Gynecol. 2012 Jan;206(1):46.e1-46.e11. doi: 10.1016/j.ajog.2011.07.024. Epub 2011 Jul 22.

PMID:
21944226
15.

Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women.

Pista A, Oliveira A, Verdasca N, Ribeiro F.

Clin Microbiol Infect. 2011 Jun;17(6):941-6. doi: 10.1111/j.1469-0691.2010.03387.x. Epub 2010 Dec 3.

16.

HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.

Baandrup L, Munk C, Andersen KK, Junge J, Iftner T, Kjær SK.

Gynecol Oncol. 2012 Feb;124(2):281-5. doi: 10.1016/j.ygyno.2011.10.020. Epub 2011 Oct 25.

PMID:
22036987
17.

Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa.

McDonald AC, Denny L, Wang C, Tsai WY, Wright TC Jr, Kuhn L.

PLoS One. 2012;7(9):e44332. doi: 10.1371/journal.pone.0044332. Epub 2012 Sep 6.

18.

Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya.

De Vuyst H, Chung MH, Baussano I, Mugo NR, Tenet V, van Kemenade FJ, Rana FS, Sakr SR, Meijer CJ, Snijders PJ, Franceschi S.

Int J Cancer. 2013 Sep 15;133(6):1441-6. doi: 10.1002/ijc.28131. Epub 2013 Mar 16.

19.

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.

Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K.

Eur J Gynaecol Oncol. 2004;25(6):689-98.

PMID:
15597844
20.

Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women.

Syrjänen K, Kulmala SM, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunjberga V, Grunjberg A, Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjänen S.

Eur J Gynaecol Oncol. 2008;29(2):114-22.

PMID:
18459542
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk